ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "De-risking psychedelics: Compass Pathways, Cybin and Atai"
Episode Synopsis
Alex Carchidi updates us on the psychedelic sector and what critical catalysts are approaching (1:30). Why Compass Pathways, Cybin, and Atai make the most sense for investors at this point (15:00). Pros and cons of 4 main industry stocks, including MindMed (29:50).Episode transcriptsShow Notes:Psychedelic Stocks = Super-Risky Biotechs Low On Cash. Make Small Bets.Psychedelic Stocks: Don't Bet On Just 1 CompanyPsychedelic Sunday: Scrutinizing Psychedelic StocksCybin: A Leading Early-Stage Psychedelics PlayFor full access to analyst ratings, stock quant scores and dividend grades: seekingalpha.com/subscriptionsCannabis Investing Podcast on Twitter
More episodes of the podcast The Cannabis Investing Podcast
Psychedelic stocks: focus on their cash
15/08/2024
In God we trust